Rachel Jennings, MD, is an Assistant Professor of Emergency Medicine and currently serves as the Assistant Program Director of the Emergency Medicine Residency at Cooper University. Dr. Jennings graduated from the University of Virginia where she was also a D1 student-athlete, serving as two-time captain of the varsity field hockey team. She received her medical degree from the Lewis Katz School of Medicine at Temple University in Philadelphia where she was awarded membership to the Alpha Omega Alpha Honor Society as well as the Gold Humanism Honor Society. Dr. Jennings completed her residency in Emergency Medicine at Vanderbilt University Medical Center, Nashville, TN.  At Vanderbilt was the recipient of the Resident Didactic Teaching Award, ACE Clerkship Resident Teaching Award, and the Resident Bedside Teaching Award. Dr. Jennings then went on to serve as the inaugural fellow of the Medical Education Fellowship at Cooper during the 2022-2023 academic year. During her fellowship she built a strong foundation of educational principles and notably completed the MERC (medical education research certificate) through CORD and was award the Presidential Grant through the Macy Foundation. She continues to pursue her educational interests through her roles as Assistant Program Director of the EM residency and core faculty member of the Medical Education fellowship.

Christopher Jones, MD, is an Associate Professor of Emergency Medicine at Cooper Medical School of Rowan University. He completed his undergraduate studies at Stanford University, and received his medical degree from the University of Michigan Medical School, where he was selected for the Alpha Omega Alpha Honor Society. Dr. Jones pursued his residency training in emergency medicine at the University of North Carolina, Chapel Hill, serving as chief resident during his final year. After his residency training he completed a fellowship in emergency medicine administration in the Christiana Care Health System.

Dr. Jones is the Director of Clinical Research in the Department of Emergency Medicine. In this role he provides mentorship to students, residents, and faculty members engaged in clinical research in the Department of Emergency Medicine. He directs the department’s journal club curriculum, as well as the Academic Associate Program, which provides opportunities for undergraduate students to participate in clinical research in the emergency department. Dr. Jones has been an investigator on numerous industry and federally-funded grants. His specific research interests include clinical trial registration, the dissemination of results from clinical trials, and the study of chronically painful or disabling conditions.

Tudor Jovin, MD is an expert in interventional and non-interventional treatment for the entire spectrum of stroke and cerebrovascular disorders. He was one of the nation’s first interventional neurologists, a medical subspecialty that uses minimally invasive technologies applied from within the vessels to diagnose and treat diseases of the arteries and veins of the head, neck, and spine such as acute stroke, carotid stenosis, intracranial aneurysm, and arteriovenous malformations.

In addition to his clinical experience, Dr. Jovin is known internationally for his research activities. He has served as principal investigator for several international clinical studies including REVASCAT, a randomized trial of endovascular therapy versus medical therapy for acute stroke within eight hours of symptoms onset conducted in Spain, and DAWN, a multicenter, international, randomized trial of endovascular therapy versus medical therapy in the beyond eight-hour time window. Both studies are considered landmark studies in the development of treatments for acute stroke and have been published in the New England Journal of Medicine. He is a member of the executive or steering committees for several multicenter national and international trials, and has participated as site principal investigator or co-investigator in multiple national and international trials.

Additionally, he serves as editorial board member for numerous medical journals. Dr. Jovin has published more than 300 articles in peer-reviewed journals or book chapters. The consequential nature of his research is evidenced by recently published studies that have identified Dr. Jovin as the highest impact author in the neuro-interventional field.

Prior to joining Cooper, Dr. Jovin was a professor of neurology and neurosurgery at the University of Pittsburgh School of Medicine and director of the Center for Neuroendovascular Therapy at the University of Pittsburgh Medical Center (UPMC). At UPMC, he also served as the director of UPMC’s Stroke Institute, one of the leading centers for stroke care, education, and research in the world.

Badal R. Juneja, PhD, DABR is a board-certified Medical Physicist at MD Anderson Cancer Center at Cooper. Dr. Juneja joined Cooper in 2016 after finishing his residency at the University of Texas MD Anderson Cancer Center in Houston. He earned his Ph.D. at the University of Florida in Gainesville under Dr. Frank Bova. Outside of his clinical responsibilities, Dr. Juneja enjoys figuring out how to use technology to make patient care more efficient and effective. He played a major role in automating several routine clinical tasks at Cooper. He has a strong passion for quality assurance activities and loves to solve problems in the clinic. He is currently looking at data-mining the record-and-verify system to assess areas where clinical practice can be improved.

Among his awards and honors: Southwest AAPM Young Investigator (2015), Lawrence Fitzgerald Award for Florida AAPM (2013), and American Nuclear Society Undergraduate Design Competition (2009).